$2.98 Billion is the total value of HealthCor Management, L.P.'s 40 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 47.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BIVV | Sell | BIOVERATIV INC | $236,840,000 | -39.2% | 4,150,000 | -35.9% | 7.94% | -43.5% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $127,898,000 | +9.0% | 2,087,110 | -18.2% | 4.29% | +1.3% |
DHR | Sell | DANAHER CORP DEL | $107,393,000 | -9.3% | 1,251,960 | -10.7% | 3.60% | -15.7% |
CELG | Sell | CELGENE CORP | $79,207,000 | -68.3% | 543,180 | -71.8% | 2.65% | -70.6% |
HAE | Sell | HAEMONETICS CORP | $65,167,000 | -11.0% | 1,452,343 | -21.7% | 2.18% | -17.4% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $54,558,000 | -20.3% | 1,202,770 | -40.8% | 1.83% | -26.1% |
EW | Sell | EDWARDS LIFESCIENCES CORP | $37,000,000 | -73.9% | 338,490 | -71.8% | 1.24% | -75.8% |
XLV | Sell | SELECT SECTOR SPDR TRsbi healthcare | $28,929,000 | -22.8% | 353,960 | -25.1% | 0.97% | -28.3% |
ISRG | Sell | INTUITIVE SURGICAL INC | $26,189,000 | -72.6% | 25,040 | -75.5% | 0.88% | -74.6% |
BMY | Sell | BRISTOL MYERS SQUIBB CO | $18,557,000 | -59.1% | 291,140 | -64.3% | 0.62% | -62.1% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,314,000 | -93.2% | 34,950 | -94.3% | 0.18% | -93.7% |
MDT | Sell | MEDTRONIC PLC | $5,141,000 | -65.4% | 66,100 | -60.5% | 0.17% | -67.9% |
BAX | Exit | BAXTER INTL INC | $0 | – | -65,610 | -100.0% | -0.14% | – |
PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -150,000 | -100.0% | -0.47% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -327,064 | -100.0% | -0.97% | – |
BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -500,000 | -100.0% | -1.00% | – |
ESRX | Exit | EXPRESS SCRIPTS HLDG COcall | $0 | – | -500,000 | -100.0% | -1.15% | – |
CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -350,000 | -100.0% | -1.18% | – |
WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -424,350 | -100.0% | -1.20% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -432,864 | -100.0% | -1.25% | – |
MD | Exit | MEDNAX INC | $0 | – | -942,730 | -100.0% | -2.05% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -1,688,060 | -100.0% | -2.76% | – |
CAH | Exit | CARDINAL HEALTH INC | $0 | – | -1,084,396 | -100.0% | -3.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
HUMANA INC | 22 | Q3 2022 | 6.6% |
BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
BIOGEN INC | 21 | Q3 2022 | 8.5% |
LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2023-05-26 |
4 | 2023-05-26 |
SC 13D/A | 2023-05-26 |
4 | 2023-04-04 |
4 | 2023-04-04 |
SC 13D/A | 2023-04-03 |
13F-HR | 2023-02-15 |
SC 13G/A | 2023-02-14 |
4 | 2023-01-04 |
4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.